Evidence map›Paper›PMID 37353790›Full record

ArticleMalaria journal2023

An active and targeted survey reveals asymptomatic malaria infections among high-risk populations in Mondulkiri, Cambodia.

Dyna Doum, David J Mclver, John Hustedt, Jeffrey Hii, Siv Sovannaroth, Dysoley Lek, Jason H Richardson, Allison Tatarsky, Neil F Lobo

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Validation of serological markers of recent exposure toThe Lancet regional health. Western Pacific · 2026
    Article
  3. Open forum infectious diseases · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Asymptomatic/submicroscopicParasite epidemiology and control · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Dyna DoumHealth Forefront Organization, Phnom Penh, Cambodia.
David J MclverMalaria Elimination Initiative, University of California, San Francisco, CA, USA. david.mciver@ucsf.edu.
John HustedtHealth Forefront Organization, Phnom Penh, Cambodia.
Jeffrey HiiMalaria Elimination Initiative, University of California, San Francisco, CA, USA.
Siv SovannarothNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Dysoley LekNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Jason H RichardsonInnovative Vector Control Consortium, Liverpool, UK.
Allison TatarskyMalaria Elimination Initiative, University of California, San Francisco, CA, USA.
Neil F LoboMalaria Elimination Initiative, University of California, San Francisco, CA, USA.
University of California, San Francisco · USCambodia National Malaria Center · KHInnovative Vector Control Consortium · GBU.S. President's Malaria Initiative · US

Funding

Amplicon deep sequencing (Amp-Seq) of malaria parasite genomes towards understanding forest transmission systemsR03AI158800 · NIAID · UNIVERSITY OF NOTRE DAME · PI LOBO, NEIL · 2021 to 2022
$173k
Innovative Vector Control Consortium A134328NIAID NIH HHS R03 AI158800
6 · The paper itself

Abstract

backgroundMalaria is a mosquito-borne disease that is one of the most serious public health issues globally and a leading cause of mortality in many developing countries worldwide. Knowing the prevalence of both symptomatic and asymptomatic malaria on a subnational scale allows for the estimation of the burden of parasitaemia present in the transmission system, enabling targeting and tailoring of resources towards greater impact and better use of available capacity. This study aimed to determine the PCR-based point prevalence of malaria infection, by parasite species, among three high-risk populations in Mondulkiri province, Cambodia: forest rangers, forest dwellers, and forest goers.

methodsA cross-sectional survey was performed during the transmission season in November and December 2021. Blood samples collected on filter paper from participants (n = 1301) from all target groups were screened for Plasmodium spp using PCR.

resultsMalaria prevalence among all study participants was 6.7% for any Plasmodium species. Malaria prevalence in the forest ranger group was 8.1%, was 6.8% in forest goers, and 6.4% in forest dwellers; all infections were asymptomatic. Plasmodium vivax was detected in all participant groups, while the few Plasmodium falciparum infections were found in goers and dwellers. 81% of all infections were due to P. vivax, 9% were due to P. falciparum, 3% due to Plasmodium cynomolgi, and the rest (7%) remained undefined. Gender was associated with malaria infection prevalence, with male participants having higher odds of malaria infection than female participants (OR = 1.69, 95% CI 1.08-2.64). Passively collected malaria incidence data from the Cambodian government were also investigated. Health facility-reported malaria cases, based on rapid diagnostic tests, for the period Jan-Dec 2021 were 521 Plasmodium vivax (0.89% prevalence), 34 P. falciparum (0.06%) and four P. falciparum + mixed (0.01%)-a total of 559 cases (0.95%) for all of Mondulkiri.

conclusionThis reservoir of asymptomatic parasitaemia may be perpetuating low levels of transmission, and thus, new strategies are required to realize the goal of eliminating malaria in Cambodia by 2025.

Indexed as

MalariaMalaria, FalciparumMalaria, VivaxPlasmodiumAnimalsAsymptomatic InfectionsCambodiaCross-Sectional StudiesFemaleHumansMaleParasitemiaPlasmodium falciparumPlasmodium vivaxAsymptomaticBlood spotsMalariaPCRPlasmodiumPrevalence

Identifiers

PMID37353790
PMCPMC10290344
OpenAlexW4381839527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.